Department of Clinical Genetics, VU University Medical Center, Amsterdam, The Netherlands.
Clin Genet. 2011 Sep;80(3):243-55. doi: 10.1111/j.1399-0004.2011.01635.x. Epub 2011 Feb 20.
Childhood brain tumours may be due to germline bi-allelic mismatch repair (MMR) gene mutations in MLH1, MSH2, MSH6 or PMS2. These mutations can also lead to colorectal neoplasia and haematological malignancies. Here, we review this syndrome and present siblings with early-onset rectal adenoma and papillary glioneural brain tumour, respectively, due to novel germline bi-allelic PMS2 mutations. Identification of MMR protein defects can lead to early diagnosis of this condition. In addition, assays for these defects may help to classify brain tumours for research protocols aimed at targeted therapies.
儿童脑肿瘤可能是由于 MLH1、MSH2、MSH6 或 PMS2 种系双等位基因突变引起的错配修复 (MMR) 基因。这些突变还可导致结直肠肿瘤和血液系统恶性肿瘤。在这里,我们回顾了这种综合征,并分别介绍了由于新型种系双等位基因 PMS2 突变导致直肠腺瘤和乳头状神经胶质脑肿瘤的兄弟姐妹。识别 MMR 蛋白缺陷可导致对此病症的早期诊断。此外,这些缺陷的检测有助于对旨在靶向治疗的研究方案中的脑肿瘤进行分类。